β-catenin and PPAR-γ levels in bone marrow of myeloproliferative neoplasm: an immunohistochemical and ultrastructural study-Reference-Cited by-同舟云学术

β-catenin and PPAR-γ levels in bone marrow of myeloproliferative neoplasm: an immunohistochemical and ultrastructural study

Published:2018-11-02 Issue:6 Volume:42 Page:498-507
ISSN:0191-3123
Container-title:Ultrastructural Pathology
language:en
Short-container-title:Ultrastructural Pathology

Author:

Subotički Tijana¹^ORCID,Mitrović Ajtić Olivera¹,Mićić Mileva¹,Kravić Stevović Tamara²,Đikić Dragoslava¹,Diklić Miloš¹,Leković Danijela³⁴^ORCID,Gotić Mirjana³⁴,Čokić Vladan P.¹

Affiliation:

1. Department of Molecular Oncology, Institute for Medical Research, University of Belgrade, Belgrade, Serbia

2. Institute of Histology and Embryology, School of Medicine, University of Belgrade, Belgrade, Serbia

3. Clinic of Hematology, Clinical Center of Serbia, Belgrade, Serbia

4. School of Medicine, University of Belgrade, Belgrade, Serbia

Funder

Serbian Ministry of Education, Science and Technological Development

Swiss National Science Foundation

Publisher

Informa UK Limited

Subject

Structural Biology,Pathology and Forensic Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/01913123.2018.1558323

Reference35 articles.

1. Histochemistry and morphometry on bone marrow biopsies in chronic myeloproliferative disorders - aids to diagnosis and classification

2. Myeloproliferative disorders

3. New molecular genetics in the diagnosis and treatment of myeloproliferative neoplasms

4. Signal transduction by Î²-catenin

5. Wnts induce migration and invasion of myeloma plasma cells

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PPARγ agonists promote the resolution of myelofibrosis in preclinical models;Journal of Clinical Investigation;2021-06-01